India's Panacea Biotec rises on $15 mln order from UNICEF
26/12/2024 05:37
** Panacea Biotec PNCA.NS gains 3.4% to 448 rupees
** Co gets letter of award from UNICEF to supply 115 mln
doses of its bivalent oral polio vaccine worth ~$15 mln
** Stock on track to extend Tuesday's gains to the day's
session; markets were shut on Wednesday for the Christmas
holiday
** PNCA up ~168% YTD; set for biggest ever annual rise
(Reporting by Yagnoseni Das in Bengaluru)
((Yagnoseni.Das@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility